Spotlight
Clinical
Blog
Partners
CE
Study finds children with residual amblyopia did not find an advantage with levodopa
A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA.
Baltimore-A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA.
Related Videos
Related Content
